This edition of Pharmacy Pearls critically reviews the data of the REDUCE-IT trial for Vascepa, which resulted in its new FDA-labeled indication for cardiovascular risk reduction with mild hypertriglyceridemia. We…
According to the CDC, Influenza B/Victoria viruses are predominant nationally, which is unusual for this time of year. H1N1 viruses are the next most common. H3N2 and B/Yamagata viruses are…
This edition of Pharmacy Pearls provides a depression management algorithm for adult and pediatric (age 12+) patients that was developed in collaboration with AHP’s Behavioral Health Integration Team. In these…
This edition of Pharmacy Pearls gives an overview of best practices for management of type 2 diabetes. In it you will find AHP endorsed principles for the management of type…
This edition of Pharmacy Pearls gives an overview of insulin lispro U-100, the new authorized generic for Humalog U-100, which is now available. Insulin lispro U-100 is considered therapeutically equivalent…
With one in four patients reporting difficulty affording prescription medications, practice staff and clinicians are often engaged with patients faced with mediation access issues related to cost and affordability. The…
This edition of Pharmacy Pearls gives an overview of the recent updates made to the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. This guideline (last updated in 2013)…
This edition of Pharmacy Pearls reviews the available epinephrine injector options for the treatment of anaphylaxis. There are several devices available (both brand and generic), and the cost to patients…
One of the 2019 AHP Pharmacy Team targets is to limit the use of Nasonex for allergic rhinitis given the availability of equally effective and far less expensive OTC products,…
The AHP Pharmacy Task Force works to identify opportunities that will enhance the quality, safety and value of medication treatment for our patients. Recently, we identified a cohort of patients…
